LONDON and SINGAPORE, Nov. 22, 2022 (GLOBE NEWSWIRE) — Claritas HealthTech (“Claritas”)a healthcare technology company specializing in advanced medical image enhancement and AI-assisted diagnostic tools to aid and optimize clinicians’ diagnostic workflow, today announces that it has chosen Bengaluru in Karnataka as a base for its Indian headquarters.
With an established presence in Singapore and a successful entry into the UK market, Claritas has chosen Bengaluru as its base for India, to meet the country’s vast and rapidly growing medical diagnostic needs. Mr. Chetan Baxi, co-founder and director of Claritas, commented: “In the last two quarters of this year, we have had strong demand from India for our technology that helps clinicians interpret medical images more accurately and efficiently. To meet this demand, and given the favorable market conditions, we have chosen to create an Indian unit dedicated to serving the Indian market. We expect these operations to begin by January 2023.”
As part of its global rollout initiative, Claritas will showcase its suite of products, including iRAD™ for X-ray image enhancement, iPET™ for accelerated PET and PET-CT/MRI acquisition and enhancement, and its suite of AI diagnostic tools, to meet the demand of the Indian health sector.
Mr. Baxi added, “India holds significant demand in the country for our products that improve diagnostic workflow without increasing capital or operating costs. Claritas enables customers to dramatically improve patient care while improving productivity of their imaging and diagnostic services.”
About Claritas HealthTech
Claritas conducts research and development activities in the fields of image enhancement, machine vision and artificial intelligence (“AI”) with a focus on medical image processing and interpretation and AI-assisted diagnosis. Claritas aims to transform the diagnostics industry with powerful and efficient software products created using image enhancement and AI technology enabling and assisting doctors and physicians in making an accurate diagnosis and to improve the lives of patients. All Claritas products, including iRAD and iPET, are fully compliant with HIPPA and GDPR requirements.
For more information, please visit www.claritashealthtech.com
For media inquiries, please contact:
Claritas HealthTech Ltd